Home Health Care Regeneron anti-cholesterol drug effective in clinical trials

Regeneron anti-cholesterol drug effective in clinical trials

SHARE

The Greenburgh-based pharmaceutical company announces its drug alirocumab reduced levels of “bad cholesterol” by 61 percent in a study.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email

Comments are closed.